Aclaris Therapeutics Inc (ACRS)
$3.97 -0.50% Close Oct 30, 2026 Live
Aclaris Therapeutics stock today
Aclaris Therapeutics closed at $3.97 on October 30, 2026, down 0.50% on the day. Over the past year it returned +59.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $554 million.
$2.00$4.00$6.00
NovJan 2026MarMayJulSep
| Period | ACRS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -24.5% | -0.9% |
| 3 months | -25.4% | +2.1% |
| Year to date | +31.9% | +11.7% |
| 1 year | +59.4% | +12.4% |
| 3 years | -13.3% | +88.5% |
| 5 years | -77.1% | +76.0% |
Key statistics
- Market value
- $554M
- Price / sales
- 67.4
- 52-week range
- $2.13 to $6.54
- Next report
- Nov 5, 2026 (estimated)
About Aclaris Therapeutics
Develops topical and systemic dermatology treatments and pharmaceuticals.
Sector: Health Care
More on Aclaris Therapeutics
- Financials: revenue, earnings and segmentsRevenue -58% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $186.04 today
No forecast, no recommendation. This page describes Aclaris Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.